Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Left Atrial Venting Versus Conventional Treatment For Left Ventricular Decompression During Venoarterial Extracorporeal Membrane Oxygenation Support (EVOLVE-ECMO Trial)

NCT03740711 is registered in ClinicalTrials.gov with Asan Medical Center as lead sponsor.

NCT NCT03740711
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03740711 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Left Atrial Venting Versus Conventional Treatment For Left Ventricular Decompression During Venoarterial Extracorporeal Membrane Oxygenation Support (EVOLVE-ECMO Trial)
Lead sponsor
Asan Medical Center
Phase
Not applicable
Overall status
Completed
Start date
December 12, 2018
Completion date
August 30, 2022
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiogenic shock, extracorporeal membrane oxygenation support, refractory pulmonary edema